HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Zhang Selected Research

Tolonium Chloride

9/2019Oleanolic acid inhibits RANKL-induced osteoclastogenesis via ER alpha/miR-503/RANK signaling pathway in RAW264.7 cells.
1/2016Morusin inhibits glioblastoma stem cell growth in vitro and in vivo through stemness attenuation, adipocyte transdifferentiation, and apoptosis induction.
7/2013Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Zhang Research Topics

Disease

812Neoplasms (Cancer)
12/2022 - 06/2002
210Inflammation (Inflammations)
08/2022 - 06/2004
146Infections
08/2022 - 04/2003
124Breast Neoplasms (Breast Cancer)
07/2022 - 07/2003
120Neoplasm Metastasis (Metastasis)
06/2022 - 11/2003
101Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 02/2004
98Lung Neoplasms (Lung Cancer)
04/2022 - 06/2002
91Fibrosis (Cirrhosis)
07/2022 - 05/2009
77Carcinogenesis
12/2022 - 03/2004
73Hepatocellular Carcinoma (Hepatoma)
07/2022 - 06/2003
66Hypoxia (Hypoxemia)
08/2022 - 07/2002
64Wounds and Injuries (Trauma)
03/2022 - 07/2003
62Carcinoma (Carcinomatosis)
04/2022 - 01/2000
54Hypertension (High Blood Pressure)
01/2022 - 01/2005
47Type 2 Diabetes Mellitus (MODY)
10/2022 - 10/2006
46Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 08/2006
44Alzheimer Disease (Alzheimer's Disease)
08/2022 - 06/2006
44Adenocarcinoma of Lung
01/2022 - 12/2005
41Asthma (Bronchial Asthma)
08/2022 - 12/2003
39Necrosis
01/2022 - 01/2001
38Glioma (Gliomas)
04/2022 - 11/2003
37Body Weight (Weight, Body)
10/2022 - 10/2002
36Pain (Aches)
03/2022 - 01/2002
36Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2003
36Ischemia
01/2022 - 07/2003
36Cognitive Dysfunction
09/2021 - 09/2007
34Melanoma (Melanoma, Malignant)
01/2022 - 11/2003
33COVID-19
12/2022 - 01/2020
33Hemorrhage
05/2022 - 02/2002
33Atherosclerosis
04/2022 - 06/2003
33Sepsis (Septicemia)
01/2022 - 05/2010
32Obesity
10/2022 - 02/2007
31Rheumatoid Arthritis
11/2022 - 01/2011
31Stroke (Strokes)
05/2022 - 08/2003
31Insulin Resistance
01/2022 - 09/2004
30Non-alcoholic Fatty Liver Disease
07/2022 - 01/2013
30Chronic Obstructive Pulmonary Disease (COPD)
03/2022 - 04/2011
26Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 01/2002
26Pathologic Constriction (Stenosis)
01/2022 - 01/2003
26Reperfusion Injury
01/2022 - 01/2011
25Mitochondrial Diseases (Mitochondrial Disease)
05/2022 - 08/2009
25Myocardial Infarction
01/2022 - 04/2011
25Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2012
25Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 01/2002
25Adenocarcinoma
01/2022 - 12/2007
24Disease Progression
06/2022 - 07/2009
23Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2009

Drug/Important Bio-Agent (IBA)

313Proteins (Proteins, Gene)FDA Link
08/2022 - 07/2002
179Biomarkers (Surrogate Marker)IBA
12/2022 - 08/2007
142Pharmaceutical PreparationsIBA
12/2022 - 06/2002
119Messenger RNA (mRNA)IBA
12/2022 - 07/2002
118Biological ProductsIBA
08/2022 - 06/2002
110MicroRNAs (MicroRNA)IBA
07/2022 - 01/2010
93CytokinesIBA
05/2022 - 01/2002
74Glucose (Dextrose)FDA LinkGeneric
01/2022 - 11/2004
56DNA (Deoxyribonucleic Acid)IBA
02/2022 - 07/2002
53EnzymesIBA
12/2022 - 07/2002
51Long Noncoding RNAIBA
07/2022 - 11/2014
51RNA (Ribonucleic Acid)IBA
02/2022 - 11/2009
46LipidsIBA
01/2022 - 12/2002
42Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2022 - 02/2004
40Interleukin-6 (Interleukin 6)IBA
04/2022 - 07/2002
39VaccinesIBA
06/2022 - 06/2002
39Oxygen (Dioxygen)IBA
05/2022 - 07/2002
38ErbB Receptors (EGF Receptor)IBA
03/2022 - 12/2005
37Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2005
37Small Interfering RNA (siRNA)IBA
01/2022 - 02/2009
36CollagenIBA
04/2022 - 05/2010
36Therapeutic UsesIBA
03/2022 - 01/2002
35AntioxidantsIBA
12/2022 - 09/2005
34Transcription Factors (Transcription Factor)IBA
06/2022 - 05/2007
34Peptides (Polypeptides)IBA
02/2022 - 12/2003
33Indicators and Reagents (Reagents)IBA
12/2022 - 07/2002
32AntigensIBA
12/2022 - 08/2003
32Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 10/2002
31Hormones (Hormone)IBA
03/2022 - 12/2005
30LigandsIBA
08/2022 - 12/2004
30C-Reactive ProteinIBA
05/2022 - 12/2002
29Cisplatin (Platino)FDA LinkGeneric
01/2022 - 08/2004
27CholesterolIBA
01/2022 - 12/2002
26Insulin (Novolin)FDA Link
10/2022 - 12/2008
26CalciumIBA
02/2022 - 08/2003
26Caspase 3 (Caspase-3)IBA
11/2021 - 09/2005
25Immunoglobulin G (IgG)IBA
08/2022 - 03/2009
25Doxorubicin (Adriamycin)FDA LinkGeneric
08/2022 - 04/2009
25CreatinineIBA
06/2022 - 08/2009
24Phosphotransferases (Kinase)IBA
08/2022 - 04/2003
24AlbuminsIBA
06/2022 - 05/2011
24CateninsIBA
05/2022 - 04/2012
24LipopolysaccharidesIBA
11/2021 - 06/2008
23Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 06/2011
23Triglycerides (Triacylglycerol)IBA
12/2021 - 12/2002

Therapy/Procedure

356Therapeutics
12/2022 - 04/2004
136Drug Therapy (Chemotherapy)
09/2022 - 03/2003
57Radiotherapy
09/2022 - 01/2009
40Immunotherapy
09/2022 - 12/2011
28Chinese Traditional Medicine (Traditional Chinese Medicine)
06/2022 - 07/2003
28Ligation
12/2021 - 12/2002
25Aftercare (After-Treatment)
01/2022 - 09/2005
24Transplantation
01/2022 - 07/2002